# Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women

> **NCT07402382** · NA · RECRUITING · sponsor: **Nutrition 21, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Glucose Monitoring, Continuous
- Whole Body Protein Metabolism
- Peri-menopausal Women
- Post-menopause

## Interventions

- **DIETARY_SUPPLEMENT:** Amylopectin-chromium blend
- **DIETARY_SUPPLEMENT:** Concentrated Amylopectin-chromium blend
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07402382
- **Lead sponsor:** Nutrition 21, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07402382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07402382, "Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07402382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*